Serum albumin changes and multivariate dynamic risk modelling in chronic heart failure

Area of Science:

• Cardiology
• Biochemistry

Background:

• Chronic heart failure (CHF) poses significant mortality risks.
• Prognostic markers are crucial for managing CHF patients.
• Serum albumin levels may offer prognostic insights.

Purpose of the Study:

• To evaluate the prognostic value of the rate of change in serum albumin over time in CHF.
• To assess the utility of multivariate dynamic risk modeling incorporating albumin changes.

Main Methods:

• Analyzed the survival implications of serum albumin change (∆albumin) in 232 systolic CHF patients, validated in 212.
• Developed and applied a multivariate dynamic risk score based on 6 simple indices, including albumin rate of change.
• Correlated risk scores with patient mortality.

Main Results:

• Greater decline in serum albumin independently predicted higher mortality (HR 0.55).
• A decline rate >0.4 g/dL/month indicated a 5-fold increased mortality risk (HR 5.13).
• Higher dynamic risk scores correlated with significantly worse 1-year survival, with scores ≥3 indicating a 12-fold increased mortality risk.

Conclusions:

• Serum albumin attenuation over time is linked to increased mortality in CHF.
• A dynamic risk model using albumin change can identify patients at substantially elevated 1-year mortality risk (up to 12-fold).